| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $10.9M | +8.3% | +4.5% |
| R&D Expense | $147K | -77.2% | -74.9% |
| SG&A Expense | $3.3M | +15.6% | +9.8% |
| Operating Income | $6.7M | +44.2% | +63.5% |
| Pre-tax Income | $10.7M | +134.5% | +144.5% |
| Income Tax | $1.9M | +86.7% | +111.5% |
| Net Income | $8.8M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $10.2M | +27.5% | -40.6% |
| Current Assets | $16.3M | -22.9% | -35.2% |
| Total Assets | $289.4M | +1.3% | -9.9% |
| Current Liabilities | $2.9M | -57.0% | -42.3% |
| Long-term Debt | $33.0M | +0.0% | +0.0% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $17.0M | — | — |
| Capital Expenditures | $512K | — | — |
| Investing Cash Flow | $45.8M | — | — |
| Financing Cash Flow | -$58.5M | — | — |
| Free Cash Flow | $16.5M | — | — |
| +148.3% |
| +153.2% |
| EPS (Basic) | $0.72 | +148.3% | +157.1% |
| EPS (Diluted) | $0.72 | +148.3% | +157.1% |
| $35.2M |
| -10.4% |
| -7.1% |
| Stockholders' Equity | $254.2M | +3.1% | -10.3% |